|
文献名
|
提交时间
|
查询结果
|
回复时间
|
|
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group
|
2017-02-15 18:41:41
|
已发送至邮箱
|
2017-02-17 10:13:22
|
|
POT1: a genetic link for familial glioma
|
2017-02-15 16:55:38
|
暂时未查到相关文献
|
2017-02-15 19:52:37
|
|
a genetic link for familial glioma
|
2017-02-15 16:55:18
|
暂时未查到相关文献
|
2017-02-15 19:52:53
|
|
Familial gliomas: cases in two pairs of brothers
|
2017-02-15 16:52:55
|
已发送至邮箱
|
2017-02-15 20:13:05
|
|
Pemetrexed combined with oxaliplatin or carboplatin as firstline treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial
|
2017-02-15 16:32:37
|
暂时未查到相关文献
|
2017-02-15 19:55:54
|
|
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced nonsmall-cell lung cancer: Four-Arm Cooperative Study in Japan
|
2017-02-15 16:32:10
|
已发送至邮箱
|
2017-02-15 20:08:50
|
|
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and ciplatin in patients with advanced nonsmall cell lung carcinoma
|
2017-02-15 16:31:39
|
暂时未查到相关文献
|
2017-02-15 20:09:46
|
|
Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-Italia
|
2017-02-15 16:31:20
|
暂时未查到相关文献
|
2017-02-15 20:17:31
|
|
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861
|
2017-02-15 16:30:55
|
暂时未查到相关文献
|
2017-02-15 20:16:13
|
|
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group
|
2017-02-15 16:30:35
|
已发送至邮箱
|
2017-02-15 20:01:05
|